Unusual skin ulcers frequently represent a diagnostic challenge. When the most common disease entities such as arterial, venous or diabetic ulcers have been excluded, the question of further differential diagnoses and procedures arises. Other possible causes include chronic inflammatory diseases, neoplasia, self-inflicted wounds, primary infectious diseases and physical/chemical damage to the skin. To narrow down the differential diagnoses, a detailed history of the patient is essential, which also needs to include events further back in time.
KirchbergerMCSchliepSBogdanC.Images in clinical tropical medicine rhinophyma-like cutaneous leishmaniasis due to Leishmania aethiopica treated successfully with liposomal amphotericin B. Am J Trop Med Hyg. 2019;100:231-232.
2.
EichnerSThoma-UszynskiSHerrgottI, et al. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers. Eur J Dermatol. 2013;23:218-223.
3.
PearsonRDSousaAQ.Clinical spectrum of leishmaniasis. Clin Infect Dis. 1996;22:1-13.
BogdanC.Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats. Ann Rheum Dis. 2012;71(suppl 2):i60-i66.
6.
TabbabiA.Review of leishmaniasis in the Middle East and North Africa. Afr Health Sci. 2019;19:1329-1337.
7.
HandlerMZPatelPAKapilaRAl-QubatiYSchwartzRA.Cutaneous and mucocutaneous leishmaniasis: clinical perspectives. J Am Acad Dermatol. 2015;73:810-897.
8.
HayaniKDandashliAWeisshaarE.Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war. Acta Derm Venereol. 2015;95:62-66.
Torres-GuerreroEQuintanilla-CedilloMRRuiz-EsmenjaudJArenasR.Leishmaniasis: a review. F1000Res. 2017;6:750.
12.
WortmannGWAronsonNEMillerRSBlazesDOsterCN.Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis. 2000;31:199-201.
13.
HerwaldtBLStokesSLJuranekDD.American cutaneous leishmaniasis in US travelers. Ann Intern Med. 1993;118:779-784.
14.
FaustinoCPinheiroL.Lipid systems for the delivery of amphotericin B in antifungal therapy. Pharmaceutics. 2020;12:1-47.
15.
SotoJAranaBAToledoJ, et al. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis. 2004;38:1266-1272.
16.
MulvaneyPAramGMaggiorePRKutznerHCarlsonJA.Delay in diagnosis: trauma- and coinfection-related cutaneous leishmaniasis because of Leishmania guyanensis infection. J Cutan Pathol. 2009;36:53-60.
17.
MartinsSSSantosAdeOLimaBDGomesCMSampaioRNR. American cutaneous leishmaniasis triggered by electrocoagulation. Rev Soc Bras Med Trop. 2018;51:108-110.
18.
McWhinneyPHMirNLoveWCBoydJF.Cutaneous leishmaniasis presenting as a postoperative granuloma. J R Soc Med. 1993;86:236-237.
19.
LongPI.Cutaneous leishmaniasis treated with metronidazole. JAMA. 1973;223:1378-1379.
20.
BaileyMSCaddyAJMcKinnonKA, et al. Outbreak of zoonotic cutaneous leishmaniasis with local dissemination in Balkh, Afghanistan. J R Army Med Corps. 2012;158:225-228.
21.
Nakkash-ChmaisseHMakkiRNahhasGKnioKNuwayri-SaltiN.Detection of Leishmania parasites in the blood of patients with isolated cutaneous leishmaniasis. Int J Infect Dis. 2011;15:e491-e494.
22.
RomeroITéllezJSuárezY, et al. Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis. PLoS Negl Trop Dis. 2010;4(9):e819.